Drug Shortage Report for INCRUSE ELLIPTA
| Report ID | 76337 |
| Drug Identification Number | 02423596 |
| Brand name | INCRUSE ELLIPTA |
| Common or Proper name | umeclidinium (as bromide) dry powder for oral inhalation |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | Umeclidinium |
| Strength(s) | 62.5MCG |
| Dosage form(s) | POWDER |
| Route of administration | INHALATION |
| Packaging size | 1x7 |
| ATC code | R03BB |
| ATC description | |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2019-02-14 |
| Estimated end date | 2019-03-05 |
| Actual end date | 2019-03-01 |
| Shortage status | Resolved |
| Updated date | 2019-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-02-19 | English | Compare |
| v2 | 2019-02-19 | French | Compare |
| v3 | 2019-02-27 | English | Compare |
| v4 | 2019-02-27 | French | Compare |
| v5 | 2019-03-01 | English | Compare |
| v6 | 2019-03-01 | French | Compare |
| v7 | 2019-03-02 | English | Compare |
Showing 1 to 7 of 7